Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Edward J Stepanski"'
Autor:
Clifford A. Hudis, Nathalie A. Lokker, Sunhee Kwon Ro, Alexander Starr, Rubina Qamar, Diana C. Medgyesy, Ellis Levine, Mark Keaton, Richard Emanuelson, Peter Eisenberg, Jeffrey J. Kirshner, Katherine Bell-McGuinn, Wei Wang, Hope S. Rugo, Edward J. Stepanski, Virginia Kaklamani, J. Thaddeus Beck, Claudine Isaacs, Grace Makari-Judson, Robert C. Hermann, Kurt W. Tauer, Lee S. Schwartzberg
PDF file - 55K, Study Drug Dosing (Safety Population)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c4e3025c6f5aa3ba9893bbb6839078
https://doi.org/10.1158/1078-0432.22447572.v1
https://doi.org/10.1158/1078-0432.22447572.v1
Autor:
Clifford A. Hudis, Nathalie A. Lokker, Sunhee Kwon Ro, Alexander Starr, Rubina Qamar, Diana C. Medgyesy, Ellis Levine, Mark Keaton, Richard Emanuelson, Peter Eisenberg, Jeffrey J. Kirshner, Katherine Bell-McGuinn, Wei Wang, Hope S. Rugo, Edward J. Stepanski, Virginia Kaklamani, J. Thaddeus Beck, Claudine Isaacs, Grace Makari-Judson, Robert C. Hermann, Kurt W. Tauer, Lee S. Schwartzberg
PDF file - 65K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14934968a920e75bea9e145972ac6c53
https://doi.org/10.1158/1078-0432.22447581
https://doi.org/10.1158/1078-0432.22447581
Autor:
Clifford A. Hudis, Nathalie A. Lokker, Sunhee Kwon Ro, Alexander Starr, Rubina Qamar, Diana C. Medgyesy, Ellis Levine, Mark Keaton, Richard Emanuelson, Peter Eisenberg, Jeffrey J. Kirshner, Katherine Bell-McGuinn, Wei Wang, Hope S. Rugo, Edward J. Stepanski, Virginia Kaklamani, J. Thaddeus Beck, Claudine Isaacs, Grace Makari-Judson, Robert C. Hermann, Kurt W. Tauer, Lee S. Schwartzberg
PDF file - 46K, Overall Survival in Prespecified Subgroups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a81ca0a60e3815ff32807bfb51020c39
https://doi.org/10.1158/1078-0432.22447575.v1
https://doi.org/10.1158/1078-0432.22447575.v1
Autor:
Clifford A. Hudis, Nathalie A. Lokker, Sunhee Kwon Ro, Alexander Starr, Rubina Qamar, Diana C. Medgyesy, Ellis Levine, Mark Keaton, Richard Emanuelson, Peter Eisenberg, Jeffrey J. Kirshner, Katherine Bell-McGuinn, Wei Wang, Hope S. Rugo, Edward J. Stepanski, Virginia Kaklamani, J. Thaddeus Beck, Claudine Isaacs, Grace Makari-Judson, Robert C. Hermann, Kurt W. Tauer, Lee S. Schwartzberg
PDF file - 44K, Sensitivity Analyses of Progression-free Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf832084b42e2c5edf58f37d5b166d0
https://doi.org/10.1158/1078-0432.22447578.v1
https://doi.org/10.1158/1078-0432.22447578.v1
Autor:
Suanna S. Bruinooge, Ash B. Alpert, Becky Koronkowski, Danielle Potter, Don S. Dizon, George Anthony Komatsoulis, Robert S. Miller, Elizabeth Garrett-Mayer, Edward J. Stepanski, Stephen C. Meersman
Publikováno v:
JCO Oncology Practice. 17:e336-e342
PURPOSE: Cancer prevalence and outcomes data, necessary to understand disparities in transgender populations, are significantly hampered because gender identity data are not routinely collected. A database of clinical data on people with cancer, Canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875291abdb087b84b633f03e12a11f85
https://doi.org/10.1200/op.20.00634
https://doi.org/10.1200/op.20.00634
Autor:
George Anthony Komatsoulis, Suanna S. Bruinooge, Whitney Rhodes, Gwynn Ison, Richard L. Schilsky, Edward J. Stepanski, Elizabeth Garrett-Mayer, Robert S. Miller, Wendy S. Rubinstein, Edward S. Kim, Sean Khozin, Caroline Schenkel, R. Donald Harvey, Thomas S. Uldrick, Li Chen
Publikováno v:
Clinical Cancer Research. 27:2430-2434
Purpose: Cancer clinical trials often accrue slowly or miss enrollment targets. Strict eligibility criteria are a major reason. Restrictive criteria also limit opportunities for patient participation while compromising external validity of trial resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5334689fb21338433e7ede49d0d926c0
https://doi.org/10.1158/1078-0432.ccr-20-3857
https://doi.org/10.1158/1078-0432.ccr-20-3857
Autor:
Mark Walker, Justin R. Smith, Gregory A. Vidal, Julie Ryder, Amit L Jain, Emily Miller, Omer Jamy, Poojitha Valasareddy, Edward J. Stepanski, Felicia Hare, Janice Nhan Mullins, Harsha Ranganath, Justin Gatwood, Rana Muhammad Usman, Lee S. Schwartzberg, Amina Chaudhry
Publikováno v:
Proc (Bayl Univ Med Cent)
The aim of this retrospective study was to assess the efficacy of topical hormonal therapy (THT) to relieve vaginal symptoms resulting from antihormonal therapy in women with hormone receptor–positive breast cancer. A total of 74 breast cancer pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5888429ea85cb97d94700d2d5d5f54c0
https://doi.org/10.1080/08998280.2020.1744059
https://doi.org/10.1080/08998280.2020.1744059
Autor:
Rebecca A. Krukowski, Ilana Graetz, Lee S. Schwartzberg, Edward J. Stepanski, Roy H. Lan, Puneet Kaur Chehal, Gregory A. Vidal, Cameron M. Kaplan, Xin Hu
Publikováno v:
JAMA Network Open
Key Points Question Are there symptom burden differences between Black and White women with early-stage breast cancer before starting chemotherapy? Findings In this cross-sectional observatonal study of 1338 patients from 1 cancer center, Black women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d872f952c9f9eec328ca67971e5709f
https://pubmed.ncbi.nlm.nih.gov/34061200
https://pubmed.ncbi.nlm.nih.gov/34061200
Autor:
Caitlin N. McKillop, Edward J. Stepanski, Ilana Graetz, Gregory A. Vidal, Janeane N. Anderson, Lee S. Schwartzberg
Publikováno v:
Journal of Cancer Survivorship. 12:431-440
PURPOSE: For postmenopausal women with hormone receptor-positive breast cancer, long-term use of aromatase inhibitors (AIs) significantly reduces the risk of cancer recurrence and improves survival. Still, many patients are nonadherent due to adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28acd4193690fb2809609945a164b34b
https://doi.org/10.1007/s11764-018-0682-z
https://doi.org/10.1007/s11764-018-0682-z
Autor:
Mohammed M. Milhem, Brian L. Samuels, Pamela E. Kaiser, Sant P. Chawla, Neeta Somaiah, Mark S. Walker, Edward J. Stepanski, Keith M. Skubitz, David C. Portnoy, Arthur P. Staddon, Dennis A. Priebat
Publikováno v:
Cancer. 123:4640-4647
BACKGROUND This phase 2, single-arm, multicenter study was designed to determine the treatment activity and safety of single-agent pazopanib in patients with unresectable or metastatic liposarcoma. METHODS Eligible patients had high-grade or intermed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69150f6da5aeccd0f3b49a012dfb95cf
https://doi.org/10.1002/cncr.30926
https://doi.org/10.1002/cncr.30926